Publications

Export 1640 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is M  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Choquet K, Yang S, Moir RD, Forget D, Larivière R, Bouchard A, Poitras C, Sgarioto N, Dicaire M-J, Noohi F et al..  2017.  Absence of neurological abnormalities in mice homozygous for the Polr3a G672E hypomyelinating leukodystrophy mutation.. Mol Brain. 10(1):13.
Sakae DY, Marti F, Lecca S, Vorspan F, Martín-García E, Morel LJ, Henrion A, Gutiérrez-Cuesta J, Besnard A, Heck N et al..  2015.  The absence of VGLUT3 predisposes to cocaine abuse by increasing dopamine and glutamate signaling in the nucleus accumbens.. Mol Psychiatry. 20(11):1448-59.
Sakae DY, Marti F, Lecca S, Vorspan F, Martín-García E, Morel LJ, Henrion A, Gutiérrez-Cuesta J, Besnard A, Heck N et al..  2015.  The absence of VGLUT3 predisposes to cocaine abuse by increasing dopamine and glutamate signaling in the nucleus accumbens.. Mol Psychiatry. 20(11):1448-59.
Sakae DY, Marti F, Lecca S, Vorspan F, Martín-García E, Morel LJ, Henrion A, Gutiérrez-Cuesta J, Besnard A, Heck N et al..  2015.  The absence of VGLUT3 predisposes to cocaine abuse by increasing dopamine and glutamate signaling in the nucleus accumbens.. Mol Psychiatry. 20(11):1448-59.
Sakae DY, Marti F, Lecca S, Vorspan F, Martín-García E, Morel LJ, Henrion A, Gutiérrez-Cuesta J, Besnard A, Heck N et al..  2015.  The absence of VGLUT3 predisposes to cocaine abuse by increasing dopamine and glutamate signaling in the nucleus accumbens.. Mol Psychiatry. 20(11):1448-59.
Sakae DY, Marti F, Lecca S, Vorspan F, Martín-García E, Morel LJ, Henrion A, Gutiérrez-Cuesta J, Besnard A, Heck N et al..  2015.  The absence of VGLUT3 predisposes to cocaine abuse by increasing dopamine and glutamate signaling in the nucleus accumbens.. Mol Psychiatry. 20(11):1448-59.
Sakae DY, Marti F, Lecca S, Vorspan F, Martín-García E, Morel LJ, Henrion A, Gutiérrez-Cuesta J, Besnard A, Heck N et al..  2015.  The absence of VGLUT3 predisposes to cocaine abuse by increasing dopamine and glutamate signaling in the nucleus accumbens.. Mol Psychiatry. 20(11):1448-59.
Sakae DY, Marti F, Lecca S, Vorspan F, Martín-García E, Morel LJ, Henrion A, Gutiérrez-Cuesta J, Besnard A, Heck N et al..  2015.  The absence of VGLUT3 predisposes to cocaine abuse by increasing dopamine and glutamate signaling in the nucleus accumbens.. Mol Psychiatry. 20(11):1448-59.
Neseliler S, Tannenbaum B, Zacchia M, Larcher K, Coulter K, Lamarche M, Marliss EB, Pruessner J, Dagher A.  2017.  Academic stress and personality interact to increase the neural response to high-calorie food cues.. Appetite. 116:306-314.
Vallianatos H, Friese K, Perez JM, Slessor J, Thind R, Dunn J, Chisholm-Nelson J, Joober R, Boksa P, Lal S et al..  2019.  ACCESS Open Minds at the University of Alberta: Transforming student mental health services in a large Canadian post-secondary educational institution.. Early Interv Psychiatry. 13 Suppl 1:56-64.
Sun H, Damez-Werno DM, Scobie KN, Shao N-Y, Dias C, Rabkin J, Koo JWook, Korb E, Bagot RC, Ahn FH et al..  2015.  ACF chromatin-remodeling complex mediates stress-induced depressive-like behavior.. Nat Med. 21(10):1146-53.
Sun H, Damez-Werno DM, Scobie KN, Shao N-Y, Dias C, Rabkin J, Koo JWook, Korb E, Bagot RC, Ahn FH et al..  2015.  ACF chromatin-remodeling complex mediates stress-induced depressive-like behavior.. Nat Med. 21(10):1146-53.
Shiri Z, Manseau F, Lévesque M, Williams S, Avoli M.  2016.  Activation of specific neuronal networks leads to different seizure onset types.. Ann Neurol. 79(3):354-65.
Takamiya A, Plitman E, Chung JKu, M Chakravarty M, Graff-Guerrero A, Mimura M, Kishimoto T.  2019.  Acute and long-term effects of electroconvulsive therapy on human dentate gyrus.. Neuropsychopharmacology.
Meyer P-F, McSweeney M, Gonneaud J, Villeneuve S.  2019.  AD molecular: PET amyloid imaging across the Alzheimer's disease spectrum: From disease mechanisms to prevention.. Prog Mol Biol Transl Sci. 165:63-106.
Meyer P-F, McSweeney M, Gonneaud J, Villeneuve S.  2019.  AD molecular: PET amyloid imaging across the Alzheimer's disease spectrum: From disease mechanisms to prevention.. Prog Mol Biol Transl Sci. 165:63-106.
Brouwers FM, Courteau J, Grégoire J-P, Moisan J, Lauzier S, Lesage A, MJ Fleury, Vanasse A.  2013.  The adequacy of pharmaceutical treatment of schizophrenia in Quebec varies with age, but is not influenced by sex or neighbourhood deprivation.. Can J Psychiatry. 58(8):456-65.
Zheng W, Xiang Y-Q, Bin Li X-, Ungvari GS, Chiu HFK, Sun F, D'Arcy C, Meng X, Xiang Y-T.  2016.  Adjunctive huperzine A for cognitive deficits in schizophrenia: a systematic review and meta-analysis.. Hum Psychopharmacol. 31(4):286-95.
McGirr A, Berlim M, Bond DJ, Chan PY, Yatham LN, Lam RW.  2017.  Adjunctive ketamine in electroconvulsive therapy: updated systematic review and meta-analysis.. Br J Psychiatry. 210(6):403-407.
Veru F, Jordan G, Joober R, Malla A, Iyer SN.  2016.  Adolescent vs. adult onset of a first episode psychosis: Impact on remission of positive and negative symptoms.. Schizophr Res. 174(1-3):183-8.
Djogo T, Robins SC, Schneider S, Kryzskaya D, Liu X, Mingay A, Gillon CJ, Kim JHyun, Storch K-F, Boehm U et al..  2016.  Adult NG2-Glia Are Required for Median Eminence-Mediated Leptin Sensing and Body Weight Control.. Cell Metab. 23(5):797-810.
Malla A, Shah JL, Lal S.  2017.  Advances and challenges in early intervention in psychosis.. World Psychiatry. 16(3):274-275.
Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JLuis, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R et al..  2014.  Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.. Lancet Neurol. 13(6):614-29.
Markova D, Richer L, Pangelinan M, Schwartz DH, Leonard G, Perron M, G Pike B, Veillette S, M Chakravarty M, Pausova Z et al..  2016.  Age- and sex-related variations in vocal-tract morphology and voice acoustics during adolescence.. Horm Behav. 81:84-96.

Pages